Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
PUT
iQIYI
IQ
$1.23B
| $286K | ﹤0.01% |
+100,000
| New | +$290K |
|
4002
AtaiBeckley Inc
ATAI
$2.66B
| $286K | ﹤0.01% |
246,550
+833
| +0.3% | +$1.11K |
|
4003
MoonLake Immunotherapeutics
MLTX
$1.57B
| $284K | ﹤0.01% |
5,641
+5,229
| +1,269% | +$245K |
|
4004
Enanta Pharmaceuticals
ENTA
$366M
| $284K | ﹤0.01% |
27,438
+20,478
| +294% | +$268K |
|
4005
Parke Bancorp
PKBK
$401M
| $284K | ﹤0.01% |
13,575
+10,237
| +307% | +$197K |
|
|
PVBC
4006
DELISTED
Provident Bancorp
PVBC
| $283K | ﹤0.01% |
26,192
+8,911
| +52% | +$95.1K |
|
|
ONIT
4007
Onity Group
ONIT
$309M
| $283K | ﹤0.01% |
8,847
+6,645
| +302% | +$181K |
|
4008
Banco de Chile
BCH
$20.9B
| $282K | ﹤0.01% |
11,151
+5,016
| +82% | +$122K |
|
|
ARC
4009
DELISTED
ARC Document Solutions, Inc.
ARC
| $282K | ﹤0.01% |
+83,457
| New | +$261K |
|
|
NXDT
4010
NexPoint Diversified Real Estate Trust
NXDT
$234M
| $282K | ﹤0.01% |
45,072
+31,731
| +238% | +$188K |
|
4011
Asure Software
ASUR
$230M
| $281K | ﹤0.01% |
31,075
+21,533
| +226% | +$192K |
|
4012
FVCBankcorp
FVCB
$335M
| $281K | ﹤0.01% |
21,529
+15,957
| +286% | +$187K |
|
4013
ProKidney
PROK
$316M
| $281K | ﹤0.01% |
146,321
+124,667
| +576% | +$283K |
|
4014
Hooker Furnishings Corp
HOFT
$150M
| $280K | ﹤0.01% |
15,463
+11,288
| +270% | +$174K |
|
4015
Innovator US Equity Power Buffer ETF October
POCT
$963M
| $279K | ﹤0.01% |
+7,164
| New | +$276K |
|
4016
Zentalis Pharmaceuticals
ZNTL
$337M
| $277K | ﹤0.01% |
75,395
+11,748
| +18% | +$42.7K |
|
4017
CALL
Trump Media & Technology Group
DJT
$2.73B
| $276K | ﹤0.01% |
+17,200
| New | +$417K |
|
4018
Hurco Companies Inc
HURC
$135M
| $276K | ﹤0.01% |
13,113
+2,779
| +27% | +$47.7K |
|
4019
BCB Bancorp
BCBP
$173M
| $276K | ﹤0.01% |
22,375
+15,702
| +235% | +$186K |
|
4020
James River Group Holdings
JRVR
$208M
| $276K | ﹤0.01% |
43,940
+32,621
| +288% | +$240K |
|
|
TPIC
4021
DELISTED
TPI Composites
TPIC
| $275K | ﹤0.01% |
60,538
+44,666
| +281% | +$183K |
|
4022
Sprott Physical Gold
PHYS
$14.6B
| $275K | ﹤0.01% |
13,500
| – | – |
|
4023
Amylyx Pharmaceuticals
AMLX
$2.26B
| $274K | ﹤0.01% |
84,572
+40,319
| +91% | +$90.6K |
|
4024
Weyco Group
WEYS
$372M
| $272K | ﹤0.01% |
8,003
+5,803
| +264% | +$189K |
|
4025
Flexsteel Industries
FLXS
$302M
| $272K | ﹤0.01% |
6,147
+1,061
| +21% | +$40.4K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.